Janssen Pharmaceuticals' New Early-Stage Compound Shows Promise Against Dengue

Janssen Pharmaceuticals, wholly-owned by Johnson & Johnson (JNJ) Wednesday announced that an early-stage compound with a novel mechanism of action showed that it could potentially treat all serotypes of dengue fever.

The company , in collaboration with the KU Leuven Rega Institute and the KU Leuven Centre for Drug Design and Discovery, said that the early-stage compound could potentially treat all serotypes of dengue fever and provide a period of protection against acquiring the dengue virus. Janssen is now moving its dengue program into clinical development.

Data from the early-stage study suggest that an antiviral compound prevents the interaction between two viral proteins (NS3 and NS4B) that play an important role in the replication process of a virus, thereby stopping the ability of the virus to reproduce.

"This scientific breakthrough shows tremendous potential to treat and prevent all four dengue serotypes and help transform the world's fight against this significant and growing public health threat," said Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson. "We are hopeful that this early-stage science can ultimately translate into a meaningful difference for at risk communities. We look forward to working with our collaborators to accelerate clinical development."

The WHO had listed dengue as one of the top ten threats in 2019, as it infects up to 400 million people, sickens up to 100 million and kills thousands each year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Major covid vaccine makers said they are investigating Omicron, the new, heavily mutated coronavirus variant that was first detected in South Africa, and working to adapt their vaccines, if needed. The World Health Organization, which named the new variant omicron, said the new strain is a "variant of concern" that could pose a higher risk of reinfection compared to the previous mutations. This Black Friday and the following holiday season, retailers across the United States are urged to keep up their inventory amid expected surge in shopping as majority of Americans wait till last minute to fill their baskets, according to certain studies. A new Oracle Retail survey, which was conducted last week and presented earlier this week, showed that 66 percent of consumers were less than Eagle, Idaho -based Flagship Food Group is recalling certain TJ Farms Select brand frozen cauliflower, citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves a limited number of cases of TJ Farms Select cauliflower that comes in 16 oz. packages with lot code 2077890089 and UPC code 75544000604-3.
Follow RTT